Wendy's board rejects $1.4 billion Peltz-led buyout bid, adopts poison pill

The Wendy's Company said Thursday that an independent committee of its board had unanimously rejected a $1.4 billion buyout proposal from a group led by activist investor Nelson Peltz's Trian Fund Management, while separately adopting a one-year shareholder rights plan designed to prevent any investor from building a larger stake without board approval. The twin moves, disclosed in a filing with the Securities and Exchange Commission, mark the most aggressive defensive step yet in a monthslong standoff between the burger chain and its largest outside shareholder.

A Deal Rebuffed

The rejected proposal, first made public on October 28, called for Trian and three co-investors — Flynn Group, the restaurant's largest franchisee; BlueFive Capital; and Sixth Street Partners — to buy out all shares they do not already own for $7.35 apiece in cash, valuing the Dublin, Ohio-based chain at roughly $1.4 billion. The Independent Committee, formed in February after Trian disclosed its stake, hired Morgan Stanley and Goldman Sachs as financial advisers and Simpson Thacher & Bartlett as legal counsel to evaluate the offer.

Its conclusion was blunt.

"The Independent Committee thoroughly evaluated this Proposal and unanimously concluded that it substantially undervalues Wendy's standalone prospects and long-term earnings potential," the committee said in the filing.

Alongside the rejection, Wendy's board adopted a limited-duration shareholder rights plan, commonly known as a poison pill, that would flood the market with discounted new shares if any single investor or group acquires 15 percent or more of the company's stock without prior board sign-off. The plan, filed as an exhibit to the same 8-K, carries a record date of November 16 and is set to expire November 3, 2027, though the board can unwind it sooner. The filing notes that Wendy's had offered the investor group a standstill agreement that would have frozen further share purchases while talks continued, and that the group turned the offer down.

Two Decades of History

Thursday's clash is the latest chapter in a relationship between Peltz and Wendy's that stretches back more than twenty years. Peltz's Triarc Companies, which then controlled Arby's, acquired Wendy's outright for about $2.3 billion in 2008 before later divesting Arby's and leaving Wendy's independent again. Trian, Peltz's current investment firm, holds roughly 16.3 percent of Wendy's shares, making it by far the company's biggest shareholder. Peltz explored a separate take-private bid in 2022 before dropping the idea in January 2023, citing improved momentum at the chain. He was named chairman emeritus in 2024, and two Trian-linked figures, executive Peter May and Peltz's son Bradley, remain on Wendy's board.

Trian's latest move came after it filed an amended ownership disclosure with regulators in February. The October 28 offer, confirmed by the company in a statement posted to its investor relations site, represented a roughly 19 percent premium to where shares had closed the prior session, and the stock jumped more than 14 percent on the news. Even so, Wendy's shares remain down about 60 percent over the past three years, a slide that has made the company a recurring target for activist pressure even as it complicates any argument that the offer price is too low.

A Chain Under Strain

The rejection landed alongside Wendy's third-quarter results, which the company also filed with regulators Thursday. Revenue for the quarter ended September 27 came in at $547.0 million, down slightly from $549.5 million a year earlier, while net income fell 66 percent to $15.1 million, from $44.3 million. Adjusted earnings came to 13 cents a share, down from 24 cents. Same-restaurant sales fell 5.7 percent in the United States and 2.2 percent internationally, marking a seventh consecutive quarter of domestic sales declines, while global systemwide sales dropped 5.9 percent to roughly $3.3 billion.

Management is pinning its turnaround hopes on an initiative called Dave's Way, a five-pillar plan covering menu, marketing, operations, digital ordering and restaurant-level profitability that chief executive Bob Wright unveiled alongside the earnings release. Wright, hired in May, is the company's fourth chief executive since 2024, a leadership churn that has unsettled franchisees and investors alike. The chain has also been thinning its store base, closing 240 U.S. restaurants in 2024 with as many as 358 more planned for 2026, and it moved to terminate its franchise agreement with Meritage Hospitality Group, one of its largest operators, which filed for bankruptcy protection last month. Rising beef, labor and packaging costs have squeezed margins further, while chains such as In-N-Out and Five Guys have taken share; industry tracker Technomic put Wendy's slice of U.S. burger-chain sales at 10.4 percent last year, down from 11.5 percent in 2019.

What Comes Next

Board chairman Art Winkleblack said in the filing that the committee's confidence rests in Wright's "proven track record" of restaurant turnarounds, and that the board believes executing Dave's Way will deliver more value to shareholders than the Trian-led offer. Trian declined to comment on the rejection. Shares were roughly flat in the session following the announcement, a muted reaction that suggests investors see the standoff as unresolved rather than settled. Wendy's is not alone in reaching for a poison pill this year: Applebee's parent Dine Brands adopted a similar defense earlier in 2026 against a takeover approach from Arkhouse Management and Cobblers Cove Capital, part of a broader pattern of restaurant and retail boards fending off opportunistic bids amid depressed valuations.

Wendy's said it does not intend to comment further on the proposal unless additional disclosure becomes appropriate or is required by law, and that the Independent Committee will continue to act in what it views as the best interests of the company and its shareholders. With the rights plan now in place through next November, Trian's options for increasing pressure without board cooperation are narrower, though the firm's board seats and sizable stake still give it an avenue to continue pushing for change from the inside. Investors are likely to get their next substantive signal on the standoff, and on whether Dave's Way is gaining traction, when Wendy's reports fourth-quarter results early next year.